RNA Drug Developer Targets Fresh Funding Channel - Benzinga

Funding & venture capital News

... financing rounds to support its research into cutting-edge nucleotide drugs. Key Takeaways: As a pioneer in gene-targeted therapy, Ribo Life hasĀ ...

Related articles